Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesPilot controlled trial of d -serine for the treatment of post-traumatic stress disorder
International Journal of Neuropsychopharmacology, 09/24/09
Heresco–Levy U et al. – These preliminary findings indicate that NMDAR glycine site–based pharmacotherapy may be effective in PTSD and warrant larger–sized clinical trials with optimized DSR dosages.
Related Articles
Serotonin polymorphisms and posttraumatic stress disorder in a trauma exposed African American population
Depression and Anxiety, 10/23/09
Relevance Score: 80%
PTSD, Combat Injury, and Headache in Veterans Returning From Iraq/Afghanistan
Headache: The Journal of Head and Face Pain, 10/15/09
Relevance Score: 80%
Resting Metabolic Activity in the Cingulate Cortex and Vulnerability to Posttraumatic Stress Disorder
Archives of General Psychiatry, 10/09/09
Relevance Score: 80%
Video games used to treat posttraumatic stress
American Medical News, 10/09/09
Relevance Score: 80%
Posttraumatic stress disorder and community violence: An update for nurse practitioners
Journal of the American Academy of Nurse Practitioners, 10/06/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
Acta Neurologica Scandinavica, 11/30/09
Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia
Journal of Pharmacology and Experimental Therapeutics, 11/30/09
New and investigational antiepileptic drugs
Expert Opinion on Investigational Drugs, 11/30/09
Sponsor
Article Search
Sponsor